Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 71.00 | |
5 mg | In stock | $ 166.00 | |
10 mg | In stock | $ 247.00 | |
25 mg | In stock | $ 415.00 | |
50 mg | In stock | $ 617.00 | |
100 mg | In stock | $ 878.00 | |
500 mg | In stock | $ 1,790.00 |
Description | Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M. |
Synonyms | AST2818 mesylate |
Molecular Weight | 664.7 |
Formula | C29H35F3N8O5S |
CAS No. | 2130958-55-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alflutinib mesylate 2130958-55-1 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR cancer Epidermal growth factor receptor AST2818 esistant mutation AST2818 Mesylate Alflutinib AST 2818 Mesylate Alflutinib Mesylate AST-2818 Mesylate AST-2818 Furmonertinib HER1 AST2818 mesylate AST 2818 NSCLC ErbB-1 Inhibitor T790M inhibit inhibitor